Dr. Ekker is Professor of Biochemistry and Molecular Biology, Mayo Clinic and Adjunct Professor in Genetics, Cell Biology and Development at the University of Minnesota. Dr. Ekker has been conducting genome engineering for 30 years. Ekker is Editor-in-Chief of the Zebrafish journal and Associate Director of the Clinical and Translational Sciences PhD program. Dr. Ekker is also a co-Founder of DGI (acquired by Immusoft), Auric Sciences, and is Chairman of the Board and co-Founder of InSciEd Out Foundation, a non-profit focused on science education reform for a healthier world. Dr. Ekker received bachelor of science degrees (Genetics and Developmental Biology, Electrical Engineering) from the University of Illinois Urbana-Champagne where he conducted genome science work with Dr. Carl Woese. Dr. Ekker earned a PhD in Molecular Biology and Genetics at the Johns Hopkins University and Howard Hughes Medical Institute. Dr. Ekker was the founding Director of the Arnold and Mabel Beckman Center for Transposon Research (now called the Center for Genome Engineering) at the University of Minnesota. The Ekker laboratory has pioneered the use of transposons, morpholino antisense oligonucleotides (including DGI’s gene discovery science, Morphant® Technology), targeted genome editing methods including nuclear and mitochondrial programming in zebrafish and other organisms.